2019\u5e7412\u67083\u65e5<\/p>\n
³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ) \u306f\u3001Shionogi Europe\u793e\u306e\u30c7\u30b8\u30bf\u30eb\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\uff06\u30a4\u30f3\u30b5\u30a4\u30c8\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3067\u3042\u308bDan Atkins\u6c0f\u3068\u3001Bayer\u793e\u306e\u7d71\u5408\u30de\u30eb\u30c1\u30c1\u30e3\u30cd\u30eb\u30de\u30fc\u30b1\u30c6\u30a3\u30f3\u30b0\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u517c\u8cac\u4efb\u8005\u3067\u3042\u308bGerhard Arnhofer\u6c0f\u304c\u30012019 ³Ô¹Ï±¬ÁÏ Commercial & Medical Summit, Europe<\/a><\/strong>\u306b\u57fa\u8abf\u8b1b\u6f14\u8005\u3068\u3057\u3066\u767b\u58c7\u3059\u308b\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n <\/p>\n Atkins\u6c0f\u3068Arnhofer\u6c0f\u306f\u3044\u305a\u308c\u3082\u3001\u3055\u307e\u3056\u307e\u306a\u696d\u7a2e\u3084\u6cbb\u7642\u9818\u57df\u3067\u306e\u30c7\u30b8\u30bf\u30eb\u7d4c\u9a13\u306b\u3064\u3044\u3066\u7d0420\u5e74\u9593\u306e\u3054\u7d4c\u9a13\u3092\u304a\u6301\u3061\u3067\u3059\u3002\u4e21\u6c0f\u306f12\u67083\u65e5\u306e\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\u306b\u53c2\u52a0\u3057\u3001\u5c02\u9580\u533b\u7642\u3084\u30b7\u30fc\u30e0\u30ec\u30b9\u306a\u30ab\u30b9\u30bf\u30de\u30fc\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u306e\u91cd\u8981\u6027\u306e\u9ad8\u307e\u308a\u306b\u5bfe\u5fdc\u3059\u308b\u305f\u3081\u306b\u3001\u5e02\u5834\u958b\u62d3\u6226\u7565\u306e\u9769\u65b0\u3092\u3069\u306e\u3088\u3046\u306b\u9032\u3081\u3066\u3044\u308b\u304b\u3001\u307e\u305f\u3001\u30d7\u30ec\u30b7\u30b8\u30e7\u30f3\u30fb\u30e1\u30c7\u30a3\u30b7\u30f3\u304c\u4eca\u65e5\u306e\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u30e2\u30c7\u30eb\u306b\u3082\u305f\u3089\u3059\u5909\u9769\u306b\u3064\u3044\u3066\u3082\u5c06\u6765\u306e\u5c55\u671b\u3092\u793a\u3057\u3066\u3044\u305f\u3060\u304d\u307e\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ Commercial & Medical Summit, Europe\u306f\u30011,200\u4eba\u3092\u8d85\u3048\u308b\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306e\u30d7\u30ed\u30d5\u30a7\u30c3\u30b7\u30e7\u30ca\u30eb\u3084\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u306e\u7686\u69d8\u306e\u3054\u6765\u5834\u304c\u898b\u8fbc\u307e\u308c\u3066\u304a\u308a\u3001\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u90e8\u9580\u304a\u3088\u3073\u30e1\u30c7\u30a3\u30ab\u30eb\u90e8\u9580\u5411\u3051\u306e\u30a4\u30d9\u30f3\u30c8\u3068\u3057\u3066\u306f\u3001\u6b27\u5dde\u6700\u5927\u898f\u6a21\u3068\u306a\u308b\u4e88\u5b9a\u3067\u3059\u3002\u6bce\u5e74\u958b\u50ac\u3057\u3066\u3044\u308b\u5f53\u30a4\u30d9\u30f3\u30c8\u306f\u4eca\u5e74\u30677\u56de\u76ee\u3068\u306a\u308a\u3001Merck KGaA\u793e\u3001Roche\u793e\u3001Bayer\u793e\u3001LEO Pharma\u793e\u3092\u306f\u3058\u3081\u3068\u3057\u305f\u3001\u4e16\u754c\u3092\u30ea\u30fc\u30c9\u3059\u308b\u30b0\u30ed\u30fc\u30d0\u30eb\u30d0\u30a4\u30aa\u88fd\u85ac\u4f01\u696d\u306e\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u306b\u3088\u308b20\u4ee5\u4e0a\u306e\u30bb\u30c3\u30b7\u30e7\u30f3\u304c\u4e88\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u6ce8\u76ee\u306e\u30bb\u30c3\u30b7\u30e7\u30f3\u306f\u4e0b\u8a18\u306e\u3068\u304a\u308a\u3067\u3059\u3002<\/p>\n 2019 ³Ô¹Ï±¬ÁÏ Commercial & Medical Summit, Europe\u306f\u300112\u67083\uff5e5\u65e5\u306b\u30d0\u30eb\u30bb\u30ed\u30ca\u3067\u958b\u50ac\u3055\u308c\u307e\u3059\u3002\u30b9\u30dd\u30f3\u30b5\u30fc\u306fAccenture\u793e\u3001Aktana\u793e\u3001Anthill\u793e\u3001Aqurance\u793e\u3001BASE life science\u793e\u3001Bright Affect\u793e\u3001C3i Solutions\u793e\u3001C-Clear Partners\u793e\u3001Capgemini\u793e\u3001Cognizant\u793e\u3001Deloitte\u793e\u3001Eagle Productivity Solutions\u793e\u3001ec4u\u793e\u3001Huron Consulting\u793e\u3001ICP\u793e\u3001LPW Training\u793e\u3001Maquetting\u793e\u3001Nub\u00e9rica\u793e\u3001OKRA Technologies\u793e\u3001Pharma Advisors\u793e\u3001ProMeasure\u793e\u3001Proxima Rsearch\u793e\u3001Pulse\u793e\u3001Purple Agency\u793e\u3001PwC\u793e\u3001RMH Media\u793e\u3001Salesforce\u793e\u3001SunTseu\u793e\u3001Sycor\u793e\u3001Trustrack\u793e\u3001Usacd\u793e\u3001Velvet\u793e\u3001Viseven\u793e\u3001Xpediant Digital\u793e\u3067\u3059\u3002<\/p>\n 2019 ³Ô¹Ï±¬ÁÏ Commercial & Medical Summit, Europe\u306f\u3001³Ô¹Ï±¬ÁÏ\u306e\u304a\u5ba2\u69d8\u304a\u3088\u3073\u3054\u62db\u5f85\u5ba2\u69d8\u5411\u3051\u306e\u30a4\u30d9\u30f3\u30c8\u3067\u3059\u3002\u8a73\u7d30\u3001\u3054\u767b\u9332\u3001\u8a73\u3057\u3044\u30a2\u30b8\u30a7\u30f3\u30c0\u306b\u3064\u3044\u3066\u306f\u3001veeva.com\/eu\/summit<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n <\/p>\n \u3010³Ô¹Ï±¬ÁÏ Systems\u793e\u306b\u3064\u3044\u3066\u3011<\/strong> \u3010Forward-looking Statements\u3011<\/strong> 2019\u5e7412\u67083\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e ³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751…<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-43098","post","type-post","status-publish","format-standard","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43098"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=43098"}],"version-history":[{"count":2,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43098\/revisions"}],"predecessor-version":[{"id":43101,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/43098\/revisions\/43101"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=43098"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=43098"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=43098"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
\n³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084\u305d\u306e\u4ed6\u306e\u898f\u5236\u3092\u53d7\u3051\u308b\u88fd\u9020\u696d\u8005\u5411\u3051\u306b\u3001\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067775\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-K for the period ended July 31, 2019. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"